2022 - Research.com Best Female Scientist Award
2022 - Research.com Best Scientist Award
Her scientific interests lie mostly in Internal medicine, Immunology, Cancer research, Transplantation and Oncology. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Surgery. Her Immunology research incorporates themes from Mutation and Hematopoietic stem cell transplantation.
Donna Neuberg focuses mostly in the field of Cancer research, narrowing it down to topics relating to Immune system and, in certain cases, Receptor. Her Transplantation study combines topics in areas such as Monoclonal, Cyclophosphamide, Bone marrow, Pathology and Survival analysis. Her Oncology research also works with subjects such as
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Immunology and Surgery. Donna Neuberg regularly links together related areas like Gastroenterology in her Internal medicine studies. Her studies in Oncology integrate themes in fields like Survival rate, Myeloid leukemia, Myelodysplastic syndromes and Lymphoma.
Her Cancer research research is multidisciplinary, relying on both Mutation, Stem cell, B cell and Gene expression profiling. Her study connects Cytotoxic T cell and Immunology. Her work is connected to Transplantation, Regimen, Cyclophosphamide, Radiation therapy and Neutropenia, as a part of Surgery.
Her primary areas of study are Internal medicine, Cancer research, Oncology, Chronic lymphocytic leukemia and Cancer. Her research ties Gastroenterology and Internal medicine together. Her Cancer research study incorporates themes from T cell, Immune system, T-cell receptor and Leukemia.
Her studies deal with areas such as Myeloid and Myeloid leukemia as well as Leukemia. Her work investigates the relationship between Oncology and topics such as Transplantation that intersect with problems in Nivolumab. Her Chronic lymphocytic leukemia research includes themes of Mutation, Transcriptome, B cell, Human leukocyte antigen and Epigenetics.
Donna Neuberg mostly deals with Internal medicine, Cancer research, Oncology, Cancer and Gastroenterology. Her Cancer research research is multidisciplinary, incorporating perspectives in T cell, Receptor, CD8 and Chronic lymphocytic leukemia. Her biological study spans a wide range of topics, including Concomitant, Refractory and Transplantation.
Her Cancer study combines topics from a wide range of disciplines, such as Clinical trial, Tyrosine kinase, Confidence interval, Disease and Survival analysis. Her Gastroenterology research includes elements of Febrile neutropenia, Chemotherapy and Minimal residual disease. Her Immunology research focuses on subjects like Disease progression, which are linked to Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal;Pierre Fontanillas;Jason Flannick;Jason Flannick;Alisa Manning.
The New England Journal of Medicine (2014)
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Margaret A. Shipp;Ken N. Ross;Pablo Tamayo;Andrew P. Weng.
(2002)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla.
Nature (2017)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
Ellen Weisberg;Paul W. Manley;Werner Breitenstein;Josef Brüggen.
Cancer Cell (2005)
Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar;Kristen Stevenson;Omar Abdel-Wahab;Naomi Galili.
The New England Journal of Medicine (2011)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau;Scott L. Carter;Petar Stojanov;Petar Stojanov;Aaron McKenna.
Cell (2013)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green;Stefano Monti;Scott J. Rodig;Przemyslaw Juszczynski.
Blood (2010)
Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease
Siddhartha Jaiswal;Pradeep Natarajan;Pradeep Natarajan;Alexander J. Silver;Christopher J. Gibson.
The New England Journal of Medicine (2017)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang;Michael S. Lawrence;Youzhong Wan;Petar Stojanov.
The New England Journal of Medicine (2011)
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Adolfo A Ferrando;Donna S Neuberg;Jane Staunton;Mignon L Loh.
Cancer Cell (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
Harvard University
Harvard University
Harvard University
Harvard University
Broad Institute
Harvard University
Harvard University
Harvard University
Queen Mary University of London
Columbia University
University of Michigan–Ann Arbor
Pennsylvania State University
Tokyo Institute of Technology
Australian National University
Technion – Israel Institute of Technology
University of Edinburgh
University of Bristol
Osaka University
National Institutes of Health
Autonomous University of Barcelona
Deakin University
University of Oxford
University of California, Berkeley
University of South Carolina
University of California, Irvine